Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:07 PM
Ignite Modification Date:
2025-12-24 @ 1:07 PM
NCT ID:
NCT00586261
Eligibility Criteria:
Inclusion Criteria:
* Age over 18 years.
* Creatinine clearance ≤ 60 ml/min by the Cockcroft-Gault equation
* Patients not anticipated to go on dialysis or have renal transplantation in the next 6 months
* Ability to provide informed consent
* Life expectancy greater than 12 months
Exclusion Criteria:
* Diabetes mellitus or a fasting blood glucose ≥ 110 mg/dL
* Acute renal failure
* Class 3 or 4 heart failure
* Liver failure, ascites, or an aspartate aminotransferase (AST) or alanine aminotransferase (ALT) two times the upper limit of normal
* Hemoglobin less than 9 mg/dL
* Multiple myeloma
* Premenopausal women not using at least 1 form of birth control
* Pregnant or nursing women
* Prisoners
* Known allergy to pioglitazone
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00586261
Study Brief:
Protocol Section:
NCT00586261